Zoomed Image
  • Ventolin Respirator Solution 10ml

Ventolin Respirator Solution 10ml

kes1,080
Description
Ventolin Respirator Solution contains salbutamol as the active ingredient. It is indicated in adults, adolescents and children aged 4 to 11 years. Ventolin Respirator Solution is indicated for use in the routine management of chronic bronchospasm unresponsive to conventional therapy, and in the treatment of acute severe asthma.
How to use
Ventolin Respirator Solution is for inhalation use only, to be breathed in through the mouth, under the direction of a physician, using a suitable nebuliser. The solution should not be injected or swallowed. Ventolin Respirator Solution may be administered intermittently or continuously. Salbutamol has a duration of action of 4 to 6 hours in most patients. For patients requiring Ventolin Respirator Solution as part of an inhalational therapy regime.
Dose; Children; 0.02 mL/kg/dose as required, up to 4 hourly. The maximum single dose is 5.00 mg (1.00 mL). Adults; 1.00 mL (5.00 mg). This dosage may be repeated as necessary every 4-6 hours. Ventolin Respirator Solution may be administered as 0.5% undiluted solution as supplied or diluted according to individual requirements. Dilution of the specified dose is often necessary
simply to allow efficient operation of the nebuliser. Where dilution is necessary or preferred, dilutions of the order of 1 mL of Ventolin Respirator. Solution 0.5% in 1 to 10 mL of normal saline are suitable. The time taken to deliver a given volume of solution will depend upon the equipment used but most nebulisers will deliver 1 mL of solution over 3 minutes and 2 mL over 8-10 minutes.
Any solution remaining in the nebuliser after completion of therapy should be discarded.
Precautions
Special warnings and precautions for use ; Ventolin Respirator Solution must only be used by inhalation, to be breathed in through the mouth, and must not be injected or swallowed. Bronchodilators should not be the only or main treatment in patients with severe or unstable asthma. Severe asthma requires regular medical assessment, including lung-function testing, as patients are at risk of severe attacks and even death. Physicians should consider using the maximum recommended dose of inhaled corticosteroid and/or oral corticosteroid therapy in these patients. Ventolin Respirator Solution should be used with care in patients known to have received large doses of other sympathomimetic drugs. Potentially serious hypokalaemia may result from β2-agonist therapy, mainly from parenteral and nebulised administration. Particular caution is advised in acute severe asthma as this effect may be potentiated by hypoxia and by concomitant treatment with xanthine derivatives, steroids and diuretics. Serum potassium levels should be monitored in such situations. Salbutamol should be administered cautiously to patients suffering from thyrotoxicosis. Ventolin Respirator Solution contains Benzalkonium chloride which may cause bronchospasm. Should not normally be prescribed with non-selective β-blocking drugs such as propranolol. Administration of drugs during pregnancy should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus.
Contraindications ; Hypersensitivity to the active substance or any of the excipients